C4 Therapeutics, Inc. (CCCC) SEC filings
CCCCNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 8/3019% above fair value
$2.77−0.12 (-4.15%)
Close on Nov 12, 2026Market cap $340.78MP/E –Yield –
SEC filings
40 of C4 Therapeutics's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Quarterly report | 10-Q | Sep 30, 2026 | Nov 5, 2026 | SEC EDGAR |
| Current report | 8-K | Nov 5, 2026 | Nov 5, 2026 | SEC EDGAR |
| Current report | 8-K | Sep 25, 2026 | Sep 25, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2026 | Aug 11, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 11, 2026 | Aug 11, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 24, 2026 | Jun 24, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 11, 2026 | Jun 11, 2026 | SEC EDGAR |
| Current report | 8-K | May 15, 2026 | May 15, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | May 12, 2026 | SEC EDGAR |
| Current report | 8-K | May 12, 2026 | May 12, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | Apr 29, 2026 | Apr 29, 2026 | SEC EDGAR |
| Current report | 8-K | Apr 10, 2026 | Apr 10, 2026 | SEC EDGAR |
| Current report | 8-K | Apr 9, 2026 | Apr 9, 2026 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2025 | Feb 26, 2026 | SEC EDGAR |
| Current report | 8-K | Feb 26, 2026 | Feb 26, 2026 | SEC EDGAR |
| Current report | 8-K | Jan 14, 2026 | Jan 14, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2025 | Nov 6, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 6, 2025 | Nov 6, 2025 | SEC EDGAR |
| Current report | 8-K | Oct 16, 2025 | Oct 16, 2025 | SEC EDGAR |
| Current report | 8-K | Oct 16, 2025 | Oct 16, 2025 | SEC EDGAR |
| Current report | 8-K | Oct 1, 2025 | Oct 1, 2025 | SEC EDGAR |
| Current report | 8-K | Sep 22, 2025 | Sep 22, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2025 | Aug 7, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 7, 2025 | Aug 7, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 18, 2025 | Jun 18, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2025 | May 7, 2025 | SEC EDGAR |
| Current report | 8-K | May 7, 2025 | May 7, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | Apr 29, 2025 | Apr 29, 2025 | SEC EDGAR |
| Current report | 8-K | Apr 14, 2025 | Apr 14, 2025 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2024 | Feb 27, 2025 | SEC EDGAR |
| Current report | 8-K | Feb 27, 2025 | Feb 27, 2025 | SEC EDGAR |
| Current report | 8-K | Jan 14, 2025 | Jan 14, 2025 | SEC EDGAR |
| Current report | 8-K | Dec 9, 2024 | Dec 9, 2024 | SEC EDGAR |
| Current report | 8-K | Nov 20, 2024 | Nov 20, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2024 | Oct 31, 2024 | SEC EDGAR |
| Current report | 8-K | Oct 31, 2024 | Oct 31, 2024 | SEC EDGAR |
| Current report | 8-K | Oct 15, 2024 | Oct 15, 2024 | SEC EDGAR |
| Current report | 8-K | Oct 11, 2024 | Oct 11, 2024 | SEC EDGAR |
| Current report | 8-K | Sep 3, 2024 | Sep 3, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2024 | Aug 1, 2024 | SEC EDGAR |
See a number that looks wrong?